Targeting the urokinase plasminogen activator pathway inhibits pancreatic cancer progression

被引：0
|
作者：
Hosen, S. M. Z. [1 ,2 ]
Haar, J. [1 ,2 ]
Xu, Z. [1 ,2 ]
Perera, C. [1 ,2 ]
Mekapogu, A. R. [1 ,2 ]
Pang, T. C. Y. [1 ,2 ]
Pothula, S. [1 ,2 ]
Goldstein, D. [1 ]
Pirola, R. [1 ]
Wilson, J. [1 ]
Buckley, B. J. [3 ,4 ,5 ]
Ranson, M. [3 ,4 ,5 ]
Apte, M. [1 ,2 ]
机构：
[1] Univ New South Wales, Pancreat Res Grp, South Western Sydney Clin Sch, Fac Med, Sydney, NSW, Australia
[2] Ingham Inst Appl Med Res, Sydney, NSW, Australia
[3] Univ Wollongong, Mol Horizons, Fac Sci Med & Hlth, Wollongong, NSW, Australia
[4] Univ Wollongong, Sch Chem & Mol Biosci, Fac Sci Med & Hlth, Wollongong, NSW, Australia
[5] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
219
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [1] Targeting the Urokinase Plasminogen Activator Pathway in Combination With Chemotherapy Inhibits Pancreatic Cancer Progression
    Hosen, S. M. Z.
    Xu, Z.
    Perera, C.
    Mekapogu, A. R.
    Pang, T. C. Y.
    Goldstein, D.
    Pirola, R. C.
    Wilson, J. S.
    Buckley, B. J.
    Ranson, M.
    Apte, M. V.
    PANCREAS, 2021, 50 (07) : 1065 - 1065
  • [2] Targeting the Urokinase Plasminogen Activator Receptor Inhibits Ovarian Cancer Metastasis
    Kenny, Hilary A.
    Leonhardt, Payton
    Ladanyi, Andras
    Yamada, S. Diane
    Montag, Anthony
    Im, Hae Kyung
    Jagadeeswaran, Sujatha
    Shaw, David E.
    Mazar, Andrew P.
    Lengyel, Ernst
    CLINICAL CANCER RESEARCH, 2011, 17 (03) : 459 - 471
  • [3] Targeting the urokinase plasminogen activation pathway reduces PDAC cancer progression.
    Chowdhury, Nayela N.
    Yang, Yi
    Shen, Yingnan
    Davey, Keely G.
    Han, Bumsoo
    Wolberg, Alisa
    Flick, Matthew J.
    Fishel, Melissa L.
    CANCER RESEARCH, 2021, 81 (13)
  • [4] Identification of urokinase plasminogen activator (uPA) and urokinase plasminogen activator receptor (uPAR) as therapeutic targets for pancreatic cancer.
    Della Croce, K
    Han, H
    Beroza, P
    Bearss, DJ
    von Hoff, DD
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3668S - 3668S
  • [5] Role of Pancreatic Stellate Cells in Pancreatic Cancer: The Urokinase Plasminogen Activator System
    Fiala-Beer, E.
    Xu, Z.
    Phillips, P.
    Yang, L.
    Goldstein, D.
    Pirola, R.
    Wilson, J.
    Apte, M.
    PANCREAS, 2010, 39 (08) : 1320 - 1320
  • [6] Targeting of urokinase-type plasminogen activator receptor in oral cancer cells inhibits invasion and metastasis in vivo
    Nozaki, Shinichi
    Endo, Yoshio
    Nakahara, Hirokazu
    Yoshizawa, Kunio
    Hashiba, Yukari
    Kawashiri, Shuichi
    Tanaka, Akira
    Nakagawa, Kiyomasa
    Yamamoto, Etsuhide
    CANCER RESEARCH, 2006, 66 (08)
  • [7] Targeting the Urokinase Plasminogen Activator Receptor (uPAR)/Urokinase Plasminogen Activator (uPA) System in Acute Myeloid Leukemia
    Mroz, Pawel
    Kosciuczuk, Ewa
    Mazan, Andrew
    Platanias, Leonidas
    MODERN PATHOLOGY, 2015, 28 : 366A - 366A
  • [8] Targeting the Urokinase Plasminogen Activator Receptor (uPAR)/Urokinase Plasminogen Activator (uPA) System in Acute Myeloid Leukemia
    Mroz, Pawel
    Kosciuczuk, Ewa
    Mazer, Andrew
    Platanias, Leonidas
    LABORATORY INVESTIGATION, 2015, 95 : 366A - 366A
  • [9] UROKINASE PLASMINOGEN-ACTIVATOR AND UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR IN BREAST-CANCER
    DUGGAN, C
    MAGUIRE, T
    MCDERMOTT, E
    OHIGGINS, N
    FENNELLY, JJ
    DUFFY, MJ
    INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (05) : 597 - 600
  • [10] RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo
    Zhou, Han
    Tang, Yaling
    Liang, Xinhua
    Yang, Xiaoqin
    Yang, Jing
    Zhu, Guiquan
    Zheng, Min
    Zhang, Chunxu
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (02) : 453 - 462
12345